Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Adapting to market pressures, embracing opportunities to foster innovation and streamline processes.
January 27, 2025
By: Dr. Amit Patel
The pharmaceutical industry is experiencing an exciting transformation, shifting from transactional partnerships to strategic alliances. This shift isn’t just about adapting to market pressures – it’s about embracing opportunities to foster innovation, streamline processes, and ultimately improve the lives of patients.
With this in play, it’s important to understand the benefits gained from effective partnerships, and the essential ingredients for building meaningful, lasting partnerships.
The Shift in Ways of Working: Transactional to Strategic
Historically, pharmaceutical partnerships were based on straightforward exchanges of goods or services. Over time, however, the industry has evolved in its approach. Influenced by a dynamic regulatory environment, the increasing complexity of drug development, and a growing focus on patient-centered care, companies are now exploring more collaborative and innovative approaches to working together and producing more efficient results for all stakeholders.
As a result, strategic alliances have become an essential way to tackle business challenges. Unlike transactional models, which often focus on short-term gains, strategic alliances aim to create long-term value. By fostering deeper collaboration, these partnerships allow companies to share risks, pool resources, and align objectives for mutual benefit.
In today’s fast-paced, competitive world, these alliances provide a foundation for agility and innovation, helping companies thrive while making a tangible difference in patient care.
Creating Value as a Strategic Partner
While strategic partnerships are an effective way forward for the industry, the path forward needs to be forged using a good understanding of the building blocks of successful collaboration. This entails going beyond the ‘usual’ business agreements and stepping foot into the ‘zone of added value’. This zone represents a shared vision for innovation, fostering a positive work culture, and resource optimization which can all help achieve improved patient outcomes.
Securing and Optimizing Capacities for Growth
Even the most innovative collaborations can falter without proper preparation. Preparing a dish to perfection requires the right ingredients and preparation time, similarly, to ensure success, companies should focus on their mutual resources and how they can be leveraged effectively.
At Pharmanovia, we value Long-term collaborations and strive for multi-year agreements where possible. This approach fosters stability and resilience, ensuring uninterrupted research/supply for critical therapies. Securing robust manufacturing and development capacities is paramount to consistently deliver on these commitments.
Key Considerations for Establishing a Strong Strategic Alliance
Beyond the right portfolio fit, building a strong strategic alliance is critical to a sustainable long-term partnership. It’s about building trust, respect and finding the right balance between planning, communication, and alignment of values.
Transparency and regular dialogue are essential for maintaining alignment and resolving any differences in opinions. Establishing a structure with well-defined roles and responsibilities can help create clarity and fosters trust and at Pharmanovia we have dedicated alliance management resources aim at ensuring regular and open dialogue with our partners.
A Look to the Future
As we look toward 2025 and beyond, I believe that the role of strategic alliances in the pharmaceutical industry will continue to grow. Cross-sector partnerships, leveraging digital health technologies, and AI-driven solutions, will become increasingly common. Sustainability will also take center stage, with partnerships focusing on reducing the environmental impact of pharmaceutical manufacturing. However, the success of the partnerships developed will be rooted in laying the right foundations, shared values, clear objectives, and open communication. As a company committed to enhancing and repurposing medicines, we’ve seen the transformative power of these partnerships firsthand. By working together, we can unlock new possibilities, improve patient outcomes, and shape the future of healthcare in meaningful ways.
Dr. Amit Patel, Founder and Executive Lead, Corporate Development, Pharmanovia. Amit founded Pharmanovia (previously Atnahs) in 2013. He was formerly the CEO and now plays a critical role as Executive Lead for Corporate Development. Prior to founding Pharmanovia, Amit was Commercial Director at Amdipharm. He qualified as a Physician in 2002 at Guys and St Thomas Hospital Medical School in London and is an alumnus of the Harvard Business School Owner & President Management program (2015-17).
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !